Advertisement
News
Subscribe to MDT Magazine News

The SCOOTER Store Expands Insurance Health Plan Relationships

June 22, 2011 6:44 am | by Bio-Medicine.Org | Comments

NEW BRAUNFELS, Texas, June 22, 2011 /- The SCOOTER Store, the nation's leading provider of power mobility solutions, announced that its business agreements with insurance companies have exceeded 200 health plan partnerships.  The contracts allow more than 170 million covered members...

TOPICS:

CardioGenics Transfers Magnetic Beads Business Unit Into its Luxspheres Inc. Subsidiary

June 22, 2011 6:42 am | by Bio-Medicine.Org | Comments

MISSISSAUGA, Ontario, June 22, 2011 /- CardioGenics Holdings Inc. (CGNH.OB) announced today the transfer of its magnetic beads business unit, which develops ultra sensitive magnetic beads for use in diagnostic devices, into its Canadian subsidiary, Luxspheres Inc. The beads business unit,...

TOPICS:

Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation

June 22, 2011 6:42 am | by Bio-Medicine.Org | Comments

SAN DIEGO, June 22, 2011 /- Cardium Therapeutics (NYSE Amex: CXM ) today announced the selection of the Cedars-Sinai Medical Center Nuclear Cardiology Core Laboratory (Cedars-Sinai Core Laboratory), Los Angeles, California, to serve as the central core lab for the Company’s Generx...

TOPICS:
Advertisement

Alzheimer's Drug Discovery Foundation Supports Axxam To Develop Novel Therapeutics for Alzheimer's Disease

June 22, 2011 6:41 am | by Bio-Medicine.Org | Comments

NEW YORK , June 22, 2011 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded a grant to Axxam SpA to develop small molecules to treat Alzheimer's disease by targeting inflammation. (Logo:...

TOPICS:

Draft Guidance for Industry and Food and Drug Administration Staff - Applying Human Factors and Usability Engineering to Optimize Medical Device Design

June 22, 2011 5:34 am | by U.S. Food & Drug Administration | Comments

FDA has developed this draft guidance document to assist industry in conducting appropriate human factors testing and identifying device features that manufacturers should optimize throughout the total product life cycle.

ProStrakan Receives FDA Approval for Rectivâ„¢ for the Treatment of Moderate to Severe Pain Associated With Chronic Anal Fissures

June 22, 2011 5:33 am | by Bio-Medicine.Org | Comments

GALASHIELS, Scotland, and BEDMINSTER, N.J., June 22, 2011 /- ProStrakan Group plc, a subsidiary of Kyowa Hakko Kirin Co. Ltd., and an international specialty pharmaceutical company, today announces that it has received approval from the U.S. Food and Drug Administration (FDA) for...

TOPICS:

Naurex Initiates Phase II Clinical Trial of Novel Antidepressant GLYX-13 in Treatment-Resistant Depression

June 22, 2011 5:33 am | by Bio-Medicine.Org | Comments

EVANSTON, Ill., June 22, 2011 /- Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced that it has initiated a Phase II clinical trial of its lead compound GLYX-13.  GLYX-13, a Glycine-site...

TOPICS:

iHealth Lab's Blood Pressure Self-Monitoring System Gets Nationwide Distribution

June 22, 2011 5:32 am | by Bio-Medicine.Org | Comments

NEW YORK, June 22, 2011 /- (Digital Experience!) -- iHealth Lab Inc., the pioneering designer and manufacturer of digital personal healthcare products including the iHealth BP3 Blood Pressure Monitoring System for iPhone, iPod touch and iPad, today announced that multiple national retail...

TOPICS:
Advertisement

CardioFocus HeartLightâ„¢ Endoscopic Ablation System to be Featured at EHRA EUROPACE 2011

June 22, 2011 3:37 am | by Bio-Medicine.Org | Comments

MARLBOROUGH, Mass., June 22, 2011 /- CardioFocus, Inc., developer of the HeartLight™ Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announced today that its technology will be the subject of several scientific sessions at the upcoming European Heart...

TOPICS:

IOF calls for improved strategies to close the treatment gap and reduce future burden of fractures

June 22, 2011 12:43 am | by International Osteoporosis Foundation | Comments

Report states 13% of projected increase in fractures by year 2025 could be avoided cost-effectively with increased uptake of osteoporosis treatments

TOPICS:

China Medical Technologies Announces Strategic Collaboration Between its Subsidiary, GP Medical, and Da An Health

June 21, 2011 11:45 pm | by Bio-Medicine.Org | Comments

BEIJING, June 22, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED ), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that its wholly-owned subsidiary, Beijing GP Medical Technologies Co., Ltd. ("GP...

TOPICS:

Oxford BioMedica Announces Ocular Programme Update

June 21, 2011 11:45 pm | by Bio-Medicine.Org | Comments

OXFORD, England, June 22, 2011 /-   - RetinoStat ® Progress in Phase I Study in Wet Age -Related Macular Degeneration   Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), a leading gene therapy company, today announces that the first dose level of...

TOPICS:

FDA's proposed changes in 510(k) process are still in their own process

June 21, 2011 8:40 pm | by Mass High Tech: The Journal of New England Technology | Comments

Some 10 months after the U.S. Food and Drug Administration announced plans to change the processes for 510(k) review and approval of many medical devices the industry is still waiting to see just what those changes will be.

The List: 30 Largest New England biotech companies

June 21, 2011 8:38 pm | by Mass High Tech: The Journal of New England Technology | Comments

Running counter to the overall economic trend, biotechnology employment grew 50.5 percent in Massachusetts from 2001 to 2010, according to the Massachusetts Biotechnology Council. Here, Mass High Tech tallied the names of the largest biotechnology firms in New England, ranked by number of employees.

TOPICS:

Life sciences-focused angel investors can be a fit for the right biotech

June 21, 2011 8:38 pm | by Mass High Tech: The Journal of New England Technology | Comments

According to local angel investors, angel involvement can be a great match for biotech under the right circumstances, and indeed can sometimes be the main source of funding for the startups.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading